Inflence of clinical and genetic characteristics on ability to achive and maintain remission in JIA patients on etanercept treatment

類似資料

• DNase I levels and disease outcome in JIA patients treated with etanercept
  著者:: Lazarević, D, 等
  出版事項: (2011)
• DNase I levels in JIA – influence of anti-TNF (etanercept) therapy
  著者:: Vojinovic, J, 等
  出版事項: (2008)
• DNase I levels and disease outcome in JIA patients treated with etanercept
  著者:: Damjanov N, 等
  出版事項: (2011-09-01)
• Influence of TNFα–308 and T676G TNF-RII polymorphism on response to etanercept and posibility to discontinue tretment
  著者:: Vojinovic, J, 等
  出版事項: (2011)
• PReS-FINAL-2142: Predictors of persistent remission following etanercept (ETN) withdrawal in patients with juvenile idiopathic arthritis (JIA)
  著者:: Perfetti, F, 等
  出版事項: (2013)